Literature DB >> 1432095

Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital.

T Sutula1, J Cavazos, G Golarai.   

Abstract

Kainic acid, an analog of the excitatory amino acid L-glutamate, induces acute hyperexcitability and permanent structural alterations in the hippocampal formation of the adult rat. Administration of kainic acid is followed by acute seizures in hippocampal pathways, neuronal loss in CA3 and the hilus of the dentate gyrus, and reorganization of the synaptic connections of the mossy fiber pathway. Rats with these hippocampal structural alterations have increased susceptibility to kindling. To evaluate the role of the acute seizures and associated hippocampal structural alterations in the development of this long-lasting susceptibility, rats that received intraventricular kainic acid were cotreated with phenobarbital (60 mg/kg, s.c., once daily). Treatment with this dose for 5 d after administration of kainic acid suppressed acute seizure activity, protected against excitotoxic damage in the dentate gyrus, reduced mossy fiber sprouting, and completely abolished the increased susceptibility to kindling associated with kainic acid. Brief treatment with phenobarbital modified the pattern of damage and synaptic reorganization in the dentate gyrus in response to seizure-induced injury, and altered the long-lasting functional effects associated with hippocampal damage. As phenobarbital treatment did not protect against neuronal damage in CA3 or other regions of the hippocampus, the circuitry of the dentate gyrus was implicated as a locus of cellular alterations that influenced the development of kindling. These observations are evidence that pharmacological intervention can prevent the development of epilepsy in association with acquired structural lesions, and suggest that pharmacological modification of cellular responses to injury can favorably alter long-term functional effects of CNS damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1432095      PMCID: PMC6575988     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  22 in total

Review 1.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year.

Authors:  G Bing; B Wilson; P Hudson; L Jin; Z Feng; W Zhang; R Bing; J S Hong
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  In search of epilepsy biomarkers in the immature brain: goals, challenges and strategies.

Authors:  Aristea S Galanopoulou; Solomon L Moshé
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 4.  The role of synaptic reorganization in mesial temporal lobe epilepsy.

Authors:  Jose E Cavazos; Devin J Cross
Journal:  Epilepsy Behav       Date:  2006-02-24       Impact factor: 2.937

5.  NMDA receptor dependence of kindling and mossy fiber sprouting: evidence that the NMDA receptor regulates patterning of hippocampal circuits in the adult brain.

Authors:  T Sutula; J Koch; G Golarai; Y Watanabe; J O McNamara
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

Review 6.  A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.

Authors:  R M Post; S R Weiss
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

7.  Hippocampal synaptic pathology in patients with temporal lobe epilepsy.

Authors:  W G Honer; T G Beach; L Hu; K Berry; K Dorovini-Zis; G R Moore; B Woodhurst
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury.

Authors:  G Golarai; A C Greenwood; D M Feeney; J A Connor
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 9.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

10.  Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.

Authors:  D G MacGregor; W J Miller; T W Stone
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.